[Postmenopausal hormone therapy after WHI and HERS].
M
M
Birkhäuser
C
C
de Geyter
P J
PJ
Keller
F
F
Luzuy
D000368:Aged; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000517:prevention & control*; D002979:Climacteric / Q000187:drug effects*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D015914:Estrogen Replacement Therapy; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D017211:Treatment Failure
D004966:Estrogens, Conjugated (USP); D017258:Medroxyprogesterone Acetate